Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study

Massaroni, Valentina; Donne, Valentina Delle; Borghetti, Alberto; Ciccullo, Arturo; Lombardi, Francesca; Giuliano, Gabriele; Farinacci, Damiano; Visconti, Elena; Tamburrini, Enrica; Giambenedetto, Simona Di

doi:10.1089/apc.2022.0030

Cited by 9 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present study assesses preferences for methods of ART among people with HIV and PrEP among people without HIV, as well as examines the correlations and reasons for these preferences in Argentina. Preference for LAI-ART, like previous studies (69–88%) 13 , 22 , 23 was high among people with HIV (91.5%), while preference for LAI-PrEP (25–74%) 3 , 12 , 15 was in the range (68%) among self-identified people without HIV or unknown status.…”

Section: Discussionsupporting

confidence: 55%

Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina

Sciannameo,

Zalazar,

Spadaccini

et al. 2024

Therapeutic Advances in Infection

View full text Add to dashboard Cite

Background: Little is known about the preferences for antiretroviral therapy (ART) administration methods, such as oral daily pills or long-acting injectable (LAI) options, as well as preferences for pre-exposure prophylaxis (PrEP) administration methods among people without HIV in Latin America. Objectives: This study aimed to assess the preferences for ART administration methods among people with HIV and PrEP methods among those without HIV, as well as to examine the correlations and reasons for these preferences. Design: We conducted a cross-sectional web-based questionnaire between April and July 2021, using social media accounts of a HIV non-governmental organization. The questionnaire was open to all adults living in Argentina, irrespective of their sexual orientation or gender identity. Methods: The questionnaire included questions on substance use, depression, chronic treatment, previous experiences with injectable medication, and HIV status. Those with HIV answered questions about ART adherence and their preferences for ART methods, while those without HIV were asked about condom use, awareness of PrEP, and their preferences for PrEP methods. Results: Out of 1676 respondents, 804 had HIV, and 872 did not. Among those with HIV, 91.5% expressed a high preference for LAI-ART, with significantly higher preferences among participants with higher educational levels, cisgender gay, bisexual, and queer men, younger individuals, and those with prior injectable medication experience. Among those without HIV, 68% preferred LAI-PrEP, and this preference was positively associated with previous positive experiences with injectable medication. Conclusion: The strong preference for LAI-ART suggests the potential for improved adherence and well-being among people with HIV. Additionally, the preference for LAI-PrEP among those without HIV emphasizes the importance of considering this option for HIV prevention strategies. This study highlights the need to offer diverse methods for ART and prevention to accommodate different preferences and improve health care outcomes in Latin America.

show abstract